基蛋生物
(603387)
| 流通市值：41.13亿 | | | 总市值：41.13亿 |
| 流通股本：5.07亿 | | | 总股本：5.07亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 275,639,997.1 | 351,595,574.28 | 536,586,628.64 | 474,266,178.51 |
| 应收票据及应收账款 | 350,426,143.31 | 355,967,181.77 | 356,397,511.26 | 425,146,736.76 |
| 应收账款 | 350,426,143.31 | 355,967,181.77 | 356,397,511.26 | 425,146,736.76 |
| 应收款项融资 | 1,042,105.7 | 1,490,105.7 | 1,000,000 | 300,000 |
| 预付款项 | 16,015,151.01 | 11,038,847.45 | 21,358,656.38 | 30,285,254.78 |
| 其他应收款合计 | 52,263,867.33 | 50,293,356.58 | 25,246,523.78 | 27,178,058 |
| 应收股利 | 2,170,319.44 | 1,558,319.44 | 2,358,319.44 | 2,358,319.44 |
| 存货 | 201,089,737.43 | 194,455,652.7 | 210,885,805.32 | 225,999,049.48 |
| 一年内到期的非流动资产 | 377,564,219.27 | 230,573,627.6 | 167,832,920.63 | 124,047,409.17 |
| 其他流动资产 | 9,823,618.06 | 12,752,940.15 | 9,156,012.71 | 17,337,954.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,879,187,131.22 | 1,857,044,281.41 | 1,930,829,694.44 | 1,844,692,386.28 |
| 非流动资产: | | | | |
| 长期应收款 | 4,250,430.68 | 4,902,566.7 | 5,213,260.03 | 6,353,986.75 |
| 长期股权投资 | 128,006,073.06 | 128,941,666.64 | 122,870,201.52 | 50,154,489.27 |
| 其他权益工具投资 | 31,000,000 | 31,000,000 | 38,500,000 | 78,500,000 |
| 其他非流动金融资产 | 81,966,270.25 | 85,933,123.18 | 91,817,222.75 | 91,752,152.88 |
| 固定资产 | 469,172,156.74 | 478,502,868.55 | 432,286,261.83 | 470,343,318.5 |
| 在建工程 | 248,359,019.48 | 225,081,025.94 | 263,981,146.62 | 255,729,565.83 |
| 使用权资产 | 3,439,003.2 | 3,895,601.7 | 6,998,838.22 | 7,822,599.39 |
| 无形资产 | 138,343,591.68 | 141,547,008.37 | 142,761,409.06 | 145,835,257.44 |
| 开发支出 | 50,083,123.48 | 48,812,605.57 | 42,070,283.69 | 40,674,009.32 |
| 商誉 | 309,713.69 | 309,713.69 | 309,713.69 | 26,135,621.88 |
| 长期待摊费用 | 5,231,217.02 | 6,253,765.32 | 7,706,183.38 | 11,457,558.26 |
| 递延所得税资产 | 49,120,328.2 | 47,885,280.85 | 46,142,858.79 | 45,097,805.87 |
| 其他非流动资产 | 634,500,483.9 | 647,265,079.57 | 707,823,324.63 | 744,870,058.92 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,843,781,411.38 | 1,850,330,306.08 | 1,908,480,704.21 | 1,974,726,424.31 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,722,968,542.6 | 3,707,374,587.49 | 3,839,310,398.65 | 3,819,418,810.59 |
| 流动负债: | | | | |
| 短期借款 | 597,762,461.97 | 575,569,384.19 | 650,379,287.4 | 627,400,646.67 |
| 交易性金融负债 | 26,601.8 | 944,785.4 | 132,957.52 | 46,584.36 |
| 应付票据及应付账款 | 150,856,472.07 | 145,885,557.51 | 141,163,626.22 | 141,328,302.22 |
| 应付账款 | 150,856,472.07 | 145,885,557.51 | 141,163,626.22 | 141,328,302.22 |
| 合同负债 | 42,112,540.72 | 34,865,199.98 | 48,320,156.77 | 39,350,212.92 |
| 应付职工薪酬 | 33,838,738.8 | 67,868,796.57 | 61,824,851.66 | 52,164,897.87 |
| 应交税费 | 21,999,097.45 | 22,333,040.39 | 26,027,545.12 | 17,262,423.98 |
| 其他应付款合计 | 41,117,890.76 | 44,395,580.66 | 41,692,011.92 | 41,971,573.18 |
| 一年内到期的非流动负债 | 3,112,550.28 | 4,376,217.46 | 9,690,347.7 | 9,700,972.75 |
| 其他流动负债 | 8,241,735.47 | 43,774,506.37 | 85,311,686.7 | 84,226,178.17 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 899,068,089.32 | 940,013,068.53 | 1,064,542,471.01 | 1,013,451,792.12 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 50,000,000 | - |
| 租赁负债 | 2,465,205.28 | 1,624,784.05 | 3,281,777.53 | 3,126,482.86 |
| 预计负债 | - | - | 1,524,520.06 | 1,524,520.06 |
| 递延收益 | 17,650,832.92 | 18,296,948.86 | 18,943,064.76 | 19,589,180.7 |
| 递延所得税负债 | 26,728,664.58 | 26,484,549.68 | 23,389,715.1 | 23,765,494.06 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 46,844,702.78 | 46,406,282.59 | 97,139,077.45 | 48,005,677.68 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 945,912,792.1 | 986,419,351.12 | 1,161,681,548.46 | 1,061,457,469.8 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 507,153,517 | 507,153,517 | 507,153,517 | 507,153,517 |
| 资本公积 | 236,181,628.1 | 236,181,628.1 | 236,181,628.12 | 236,181,628.12 |
| 其他综合收益 | 1,006,591.96 | 1,016,207.05 | 775,339.61 | 1,063,066.79 |
| 专项储备 | 10,245,418.26 | 9,142,621.41 | 8,047,308.66 | 5,595,138.35 |
| 盈余公积 | 245,767,888.31 | 245,767,888.31 | 224,287,927.79 | 224,287,927.79 |
| 未分配利润 | 1,684,006,421.49 | 1,619,698,992.14 | 1,592,961,304.34 | 1,604,093,553.2 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,684,361,465.12 | 2,618,960,854.01 | 2,569,407,025.52 | 2,578,374,831.25 |
| 少数股东权益 | 92,694,285.38 | 101,994,382.36 | 108,221,824.67 | 179,586,509.54 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,777,055,750.5 | 2,720,955,236.37 | 2,677,628,850.19 | 2,757,961,340.79 |
| 负债和股东权益合计 | 3,722,968,542.6 | 3,707,374,587.49 | 3,839,310,398.65 | 3,819,418,810.59 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 保留意见 | | |